BRAF and non-small cell lung carcinoma: Taken together, our findings indicate that BRAF mutations are likely to stimulate proliferation and induce hyperplasia, however early lesions with mutated BRAF rarely progress to malignant disease, unless they are overlapping with other oncogenic mutations found in NSCLC.